NCT00231556View on ClinicalTrials.gov

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

PHASE3CompletedINTERVENTIONAL

Enrollment

750

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

September 30, 2003

Conditions

EpilepsySeizuresEpilepsies, PartialEpilepsy, GeneralizedEpilepsy, Tonic-Clonic

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00231556 - A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy | Biotech Hunter | Biotech Hunter